Ergenç, İ. Et Al. 2023. Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B.. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.34, no.2 , 156-160.

Ergenç, İ., Kani, H. T., Karabacak, M., Cömert Özer, E., Mehdiyev, S., Jafarov, F., ... Abacar, K. Y.(2023). Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B.. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.34, no.2, 156-160.

Ergenç, İlkay Et Al. "Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B.," The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.34, no.2, 156-160, 2023

Ergenç, İlkay Et Al. "Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B.." The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.34, no.2, pp.156-160, 2023

Ergenç, İ. Et Al. (2023) . "Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B.." The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.34, no.2, pp.156-160.

@article{article, author={İlkay Ergenç Et Al. }, title={Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B.}, journal={The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology}, year=2023, pages={156-160} }